Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A POLLACK

Showing results (601-610 of 603) with videos related to

Pageof 61
Sort By:
You have reached the last page of results.This site can display upto 603 results.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer CommitteeH Sandler, W U Shipley, L Gomella, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research ProgramP Okunieff, E Hammond, D Grignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trialsA Dal Pra, P Ghadjar, H M Ryu, et al.
Pageof 61

Showing results (601-610 of 603) with videos related to

Sort By:
Pageof 61
You have reached the last page of results.This site can display upto 603 results.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer CommitteeH Sandler, W U Shipley, L Gomella, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2001
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research ProgramP Okunieff, E Hammond, D Grignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trialsA Dal Pra, P Ghadjar, H M Ryu, et al.
Pageof 61